New York State Common Retirement Fund’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$399K Hold
42,355
﹤0.01% 2096
2026
Q1
$345K Hold
42,355
﹤0.01% 2041
2025
Q4
$285K Hold
42,355
﹤0.01% 2146
2025
Q3
$367K Hold
42,355
﹤0.01% 2056
2025
Q2
$267K Hold
42,355
﹤0.01% 2132
2025
Q1
$271K Hold
42,355
﹤0.01% 2108
2024
Q4
$341K Hold
42,355
﹤0.01% 2080
2024
Q3
$535K Sell
42,355
-15,800
-27% -$204K ﹤0.01% 1924
2024
Q2
$736K Buy
58,155
+35,455
+156% +$357K ﹤0.01% 1890
2024
Q1
$109K Sell
22,700
-90
-0.4% -$417 ﹤0.01% 2704
2023
Q4
$109K Sell
22,790
-127
-0.6% -$777 ﹤0.01% 2720
2023
Q3
$166K Buy
22,917
+254
+1% +$2.03K ﹤0.01% 2506
2023
Q2
$168K Sell
22,663
-36,158
-61% -$284K ﹤0.01% 2575
2023
Q1
$408K Sell
58,821
-18,076
-24% -$166K ﹤0.01% 2276
2022
Q4
$791K Sell
76,897
-366
-0.5% -$6.46K ﹤0.01% 2088
2022
Q3
$1.41M Sell
77,263
-5,875
-7% -$255K ﹤0.01% 1793
2022
Q2
$4.28M Sell
83,138
-3,532
-4% -$183K 0.01% 1269
2022
Q1
$6.38M Buy
86,670
+1,468
+2% +$131K 0.01% 1175
2021
Q4
$12.2M Sell
85,202
-171
-0.2% -$29.4K 0.01% 903
2021
Q3
$17.7M Buy
85,373
+319
+0.4% +$70.3K 0.02% 726
2021
Q2
$18.1M Buy
85,054
+30,356
+55% +$5.56M 0.02% 722
2021
Q1
$9.92M Sell
54,698
-900
-2% -$179K 0.01% 945
2020
Q4
$6.2M Sell
55,598
-200
-0.4% -$21.3K 0.01% 1163
2020
Q3
$6.05M Buy
55,798
+2,400
+4% +$292K 0.01% 1088
2020
Q2
$4.45M Buy
53,398
+35,000
+190% +$1.34M 0.01% 1202
2020
Q1
$250K Hold
18,398
﹤0.01% 2354
2019
Q4
$73K Hold
18,398
﹤0.01% 3068
2019
Q3
$92K Hold
18,398
﹤0.01% 3052
2019
Q2
$108K Sell
18,398
-1
-0% -$8 ﹤0.01% 3067
2019
Q1
$203K Sell
18,399
-1,112
-6% -$35.1K ﹤0.01% 2717
2018
Q4
$718K Buy
19,511
+495
+3% +$19.2K ﹤0.01% 2097
2018
Q3
$715K Hold
19,016
﹤0.01% 2266
2018
Q2
$510K Buy
19,016
+2,420
+15% +$81.8K ﹤0.01% 2444
2018
Q1
$697K Buy
16,596
+1,924
+13% +$77.3K ﹤0.01% 2210
2017
Q4
$364K Sell
14,672
-190
-1% -$4.63K ﹤0.01% 2496
2017
Q3
$339K Hold
14,862
﹤0.01% 2548
2017
Q2
$342K Sell
14,862
-1,798
-11% -$35.3K ﹤0.01% 2605
2017
Q1
$426K Hold
16,660
﹤0.01% 2455
2016
Q4
$420K Sell
16,660
-1,369
-8% -$39.9K ﹤0.01% 2439
2016
Q3
$750K Buy
18,029
+565
+3% +$72.9K ﹤0.01% 2131
2016
Q2
$2.54M Sell
17,464
-5,164
-23% -$592K ﹤0.01% 1515
2016
Q1
$2.33M Hold
22,628
﹤0.01% 1517
2015
Q4
$3.8M Hold
22,628
0.01% 1337
2015
Q3
$3.2M Sell
22,628
-2,366
-9% -$531K 0.01% 1385
2015
Q2
$5.57M Sell
24,994
-7,388
-23% -$1.3M 0.01% 1293
2015
Q1
$5.36M Buy
32,382
+2,247
+7% +$365K 0.01% 1178
2014
Q4
$3.57M Buy
30,135
+4,950
+20% +$517K 0.01% 1373
2014
Q3
$2.1M Hold
25,185
﹤0.01% 1602
2014
Q2
$2.33M Buy
+25,185
New +$2.21M ﹤0.01% 1597

Other funds holding NVAX

New York State Common Retirement Fund's NVAX Position: Q2 2026 in Review

New York State Common Retirement Fund held its Novavax (NVAX) position steady in Q2 2026 at 42,355 shares worth $399K. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

New York State Common Retirement Fund first reported a position in NVAX in Q2 2014 and has held it in 49 quarters since. The position peaked at $18.1M in Q2 2021. 89 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • New York State Common Retirement Fund held 42,355 shares of Novavax worth $399K as of Q2 2026.
  • New York State Common Retirement Fund left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2096 holding.
  • New York State Common Retirement Fund first reported a position in Novavax in Q2 2014 and has held it in 49 quarters since.
  • New York State Common Retirement Fund's Novavax position peaked at $18.1M in Q2 2021.
  • 89 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.